NCT07199179View on ClinicalTrials.gov

Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia

Active, not recruitingOBSERVATIONAL

Enrollment

456

Participants

Timeline

Start Date

November 24, 2024

Primary Completion Date

November 24, 2025

Study Completion Date

November 24, 2025

Conditions

Depression - Major Depressive DisorderDepression DisorderSuicide

Trial Locations (1)

Unknown

Chu Montpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER